Intersect Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Intersect Capital's IDXX Position: Q2 2022 in Review
Intersect Capital sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 479 shares — an estimated $262K sold.
Intersect Capital first reported a position in IDXX in Q1 2021 and held it in 5 quarters. The position peaked at $469K in Q4 2021. 957 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.
- Intersect Capital reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
- Intersect Capital sold 479 Idexx Laboratories shares in Q2 2022, an estimated $262K.
- Intersect Capital first reported a position in Idexx Laboratories in Q1 2021 and held it in 5 quarters.
- Intersect Capital's Idexx Laboratories position peaked at $469K in Q4 2021.
- 957 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.
Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.